ELAN FY 2025 Earnings — Elanco Animal Health Incorporated Revenue & Financial Results | Market Cap Arena

ELANElanco Animal Health Incorporated

$12B

FY 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$4.7B+6.2% YoY

Gross Profit

$2.0B43.5% margin

Operating Income

$252M5.3% margin

Net Income

-$232M-4.9% margin

EPS (Diluted)

$-0.47

Cash Flow

Operating Cash Flow

$560M

Free Cash Flow

$284M

Stock-Based Comp.

$68M

Balance Sheet

Total Assets

$13.4B

Total Liabilities

$6.8B

Stockholders' Equity

$6.5B

Cash & Equivalents

$545M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.7B	$4.4B	+6.2%
Gross Profit	$2.0B	$1.9B	+7.4%
Operating Income	$252M	$251M	+0.4%
Net Income	-$232M	$338M	-168.6%